Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study

Autor: Paola Ghione, M Lia Palomba, Hervé Ghesquieres, Sabela Bobillo, Anik R Patel, Myrna Nahas, Steve Kanters, Kevin Deighton, Anthony Hatswell, Long Ma, Eve H. Limbrick-Oldfield, Julia Thornton Snider, Sally W. Wade, Maria Teresa Riberio, John Radford, Sara Beygi, John Gribben

Publikováno v: Haematologica, Vol 108, Iss 3 (2022)

The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom existing data are limited. SCHOLAR-5 is a retrospective cohort study using data from adult

Externí odkaz: https://doaj.org/article/604a1f99ccae4ab1b8ca2279a5620a97

Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States

Autor: Rohini K. Hernandez, Sally W. Wade, Adam Reich, Melissa Pirolli, Alexander Liede, Gary H. Lyman

Publikováno v: BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)

Abstract Background Bone metastases commonly occur in conjunction with solid tumors, and are associated with serious bone complications. Population-based estimates of bone metastasis incidence are limited, often based on autopsy data, and may not ref

Externí odkaz: https://doaj.org/article/7b025d7401184083b5e9ce3b7fd9cb68

Network Meta-Analysis (NMA) of Chimeric Antigen Receptor (CAR) T-Cell Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after 2 Prior Treatments Using Published Comparative Studies

Autor: Frederick L. Locke, Sattva S. Neelapu, Markqayne D. Ray, Eve H Limbrick-Oldfield, Sally W Wade, Steve Kanters, Anik R. Patel, Olalekan O. Oluwole

Publikováno v: Blood. 140:7516-7518

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::55d20b3debfe661fdfbc38f4a1acc10e
https://doi.org/10.1182/blood-2022-169812

A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma

Autor: M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi, Anthony J Hatswell, Steve Kanters, Eve H. Limbrick-Oldfield, Sally W Wade, Markqayne D Ray, Jessica Owen, Sattva S Neelapu, John Gribben, John Radford, Sabela Bobillo

Publikováno v: Palomba, M L, Ghione, P, Patel, A R, Nahas, M, Beygi, S, Hatswell, A J, Kanters, S, Limbrick-Oldfield, E H, Wade, S W, Ray, M D, Owen, J, Neelapu, S S, Gribben, J, Radford, J & Bobillo, S 2023, ' A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma ', Expert Review of Anticancer Therapy, vol. 23, no. 2, pp. 199-206 . https://doi.org/10.1080/14737140.2023.2171994
Scientia

Follicular lymphoma; Axicabtagene ciloleucel; Comparative effectiveness Limfoma fol·licular; Axicabtagene ciloleucel; Eficàcia comparativa Linfoma folicular; Axicabtagene ciloleucel; Eficacia comparativa Background In the ZUMA-5 trial (Clinical tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d727090bb434c68e1185c778daaf38

Impact of Cariprazine on Weight and Blood Pressure in Bipolar I Depression: A Real-World Study Using Electronic Medical Records

Autor: Christoph U. Correll, François Laliberté, Guillaume Germain, Sean D. MacKnight, Huy-Binh Nguyen, Mousam Parikh, Sally W. Wade, Andrew J. Cutler

Publikováno v: CNS Spectrums. 28:216-216

IntroductionPatients with a severe mental illness such as bipolar I disorder (BP-I) have a higher prevalence of obesity and related metabolic comorbidities than the general population. This study evaluated the impact of cariprazine on weight and bloo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0bea0fa8af08ae9cc9d288c43d414737
https://doi.org/10.1017/s1092852923001293